INMB MEXC RealStocks
Own real INMB shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 15:04:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
INmune Bio Inc. (INMB) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.06, with a market capitalization of $34.05M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.05 to $2.60. This page covers its latest market performance, valuation, price trends and company information.
$34.05M | |
$1.10 | |
$1.15 | |
$1.05 | |
$1.10 | |
38.78K | |
324.46K | |
-- | |
$2.60 | |
$1.05 | |
-- | |
-- |
INmune Bio Inc. (INMB) is currently trading at $1.06 as of 2026-11-12 15:03:00, down 2.73% ($0.03) from the previous close of $1.10
During today's regular trading session, INMB has traded between $1.05 and $1.15, with a trading volume of 38.78K shares. The current price is near the lower end of today's range.
Over the past seven days, INmune Bio Inc. (INMB) moved from $1.32 to $1.06, representing a decline of 20.08% ($0.27).
The stock traded between $1.05 and $1.42 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 403.50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.3%
INMB is currently trading at $1.06, placing it 0.3% of the way from its 52-week low of $1.05 to its 52-week high of $2.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 21 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for INmune Bio Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of INmune Bio Inc. (INMB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to INMB, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between INMB shares and USD.
INMB Shares to USD
1.00 INMB shares = 1.055 USD
Calculations are estimates based on the latest available price and are for reference only.